This topic contains a solution. Click here to go to the answer

Author Question: The _____________ monitors the amount of conflict between nodes at the response level and engages ... (Read 21 times)

Haya94

  • Hero Member
  • *****
  • Posts: 558
The _____________ monitors the amount of conflict between nodes at the response level and engages executive attention as conflict increases.
 
  a. conflict monitor c. task monitor
  b. response monitor d. attentional controller

Question 2

The attentional controller activates nodes in a neural-network based on _________________.
 
  a. similarity across representations c. amount of conflict in the response layer
  b. signal strength d. relevance to goals



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jordin Calloway

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: a

Answer to Question 2

Answer: d




Haya94

  • Member
  • Posts: 558
Reply 2 on: Jun 20, 2018
:D TYSM


ebonylittles

  • Member
  • Posts: 318
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library